News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Evolution and trajectory of B-cell targeted therapies in rheumatic diseases
depositphotos.com
Mar 29, 2025, 16:53

Evolution and trajectory of B-cell targeted therapies in rheumatic diseases

The Lancet shared an article by Lucy Marie Carter, et al on X:

“New treatments such as rituximab and belimumab have aided our understanding on treating autoimmune diseases caused by issues with B-cells.

A new Review in The Lancet Rheumatology reflects on 20 years of insights drawn from B-cell targeted therapies.”

Evolution and trajectory of B-cell targeted therapies in rheumatic diseases

Authors: Lucy Marie Carter, Michael R Ehrenstein, Prof Edward M Vital

Evolution and trajectory of B-cell targeted therapies in rheumatic diseases

More posts featuring The Lancet.

 

autoimmune diseases belimumab cancer OncoDaily Oncology Rituximab The Lancet The Lancet Rheumatology
Special Coverage
Blog
Mar 30, 2025, 16:09
Hedley Lewis: No Family Should Face Childhood Cancer and Life-Threatening Blood Disorders Alone
Blog
Mar 30, 2025, 16:06
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Blog
Mar 30, 2025, 16:03
Research drives progress, and advocacy fuels change - Fight Colorectal Cancer
Blog
Mar 30, 2025, 15:52
St. Baldrick's Foundation - Honoring our heroes on National Doctors' Day
Blog
Mar 30, 2025, 15:48
Our experts are in Orlando for NCCN2025 - Roswell Park
Blog
Mar 30, 2025, 15:42
Peter Pisters: Honoring MD Anderson Cancer Center's Physicians on Doctors' Day for their commitment
Blog
Mar 30, 2025, 15:41
New NCI Funding Opportunity to New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
Blog
Mar 30, 2025, 15:37
How PROs and CROs provide different but equally vital information - ESMO
Blog
Mar 30, 2025, 15:24
EORTC is Looking For a Medical Liaison Officer in Brussels
Blog
Mar 30, 2025, 15:14
Leandro Jonata Carvalho: Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference
Science
Mar 30, 2025, 15:09
Katsuaki Maehara: Genome doubling identified as a key factor in resistance for EGFRm lung cancer
Blog
Mar 30, 2025, 15:00
Jae Won Joh: Bill Gates Predicts AI Will Replace Doctors – But Who Takes on the Liability?